LEADER 05901nam 2200697zu 450 001 9910967735203321 005 20251117071008.0 010 $a1-4963-3828-6 035 $a(CKB)3710000000587171 035 $a(SSID)ssj0001613610 035 $a(PQKBManifestationID)16338800 035 $a(PQKBTitleCode)TC0001613610 035 $a(PQKBWorkID)13505700 035 $a(PQKB)10289088 035 $a(MiAaPQ)EBC4786218 035 $a(BIP)71618887 035 $a(BIP)52707051 035 $a(EXLCZ)993710000000587171 100 $a20160829d2016 uy | 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aLymphomas and leukemias 205 $a10th ed. 210 31$a[Place of publication not identified]$cWolters Kluwer Health$d2016 215 $a1 online resource (1569 pages) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a1-4963-3394-2 327 $aIntro -- Contributors -- Part I Principles of Oncology -- 1. The Cancer Genome -- 2. Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- 3. Molecular Methods in Cancer -- Part II Etiology and Epidemiology of Cancer -- Section 1. Etiology of Cancer -- 4. Tobacco -- 5. Oncogenic Viruses -- 6. Inflammation -- 7. Chemical Factors -- 8. Physical Factors -- 9. Dietary Factors -- 10. Obesity and Physical Activity -- Section 2. Epidemiology of Cancer -- 11. Epidemiologic Methods -- 12. Trends in United States Cancer Mortality -- Part III Cancer Therapeutics -- 13. Essentials of Radiation Therapy -- 14. Cancer Immunotherapy -- 15. Pharmacokinetics and Pharmacodynamics of Anticancer Drugs -- 16. Pharmacogenomics -- 17. Alkylating Agents -- 18. Platinum Analogs -- 19. Antimetabolites -- 20. Topoisomerase Interactive Agents -- 21. Antimicrotubule Agents -- 22. Kinase Inhibitors as Anticancer Drugs -- 23. Histone Deacetylase Inhibitors and Demethylating Agents -- 24. Proteasome Inhibitors -- 25. Poly (ADP-ribose) Polymerase Inhibitors -- 26. Miscellaneous Chemotherapeutic Agents -- 27. Hormonal Agents -- 28. Antiangiogenesis Agents -- 29. Monoclonal Antibodies -- 30. Assessment of Clinical Response -- Part IV Cancer Prevention and Screening -- 31. Tobacco Use and the Cancer Patient -- 32. Role of Surgery in Cancer Prevention -- 33. Cancer Risk-Reducing Agents -- 34. Cancer Screening -- 35. Genetic Counseling -- Part V Lymphomas and Leukemias -- Section 1. Leukemias and Lymphomas in Children -- 36. Leukemias and Lymphomas of Childhood -- Section 2. Lymphomas in Adults -- 37. Molecular Biology of Lymphomas -- 38. Hodgkin's Lymphoma -- 39. Non-Hodgkin's Lymphoma -- 40. Cutaneous Lymphomas -- 41. Primary Central Nervous System Lymphoma -- Section 3. Leukemias and Plasma Cell Tumors -- 42. Molecular Biology of Acute Leukemias. 327 $a43. Management of Acute Leukemias -- 44. Molecular Biology of Chronic Leukemias -- 45. Chronic Myelogenous Leukemia -- 46. Chronic Lymphocytic Leukemias -- 47. Myelodysplastic Syndromes -- 48. Plasma Cell Neoplasms -- Index. 330 $aSelected from the world's leading comprehensive cancer textbook, this tightly focused resource provides you with the practical, cutting-edge information you need to provide the best cancer care to each patient. Lymphomas and Leukemias: From Cancer: Principles & Practice of Oncology, 10th Edition, offers a complete and balanced view of this rapidly changing field, meeting the needs of oncology/hematology practitioners, fellows, and others who need an in-depth understanding of leukemias and lymphomas. The print reference gives you the solid, dependable guidance you have come to expect from this outstanding title, and the Inkling version features new quarterly updates written by a team of experts selected by the authors.Delivers focused, comprehensive information on leukemias and lymphomas drawn from the world's leading cancer textbook, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology.Covers the full range of adult lymphomas and leukemias, including the molecular biology of lymphomas and acute and chronic leukemias; Hodgkin's lymphoma; non-Hodgkin's lymphoma; cutaneous lymphomas; management of acute and chronic leukemias, future directions and new treatments; myelodysplastic syndromes; plasma cell neoplasms; and more.Includes comprehensive information on leukemias and lymphomas of childhood, including supportive, long-term, palliative, and hospice care.Discusses in detail the growing importance of prevention and screening, giving you the understanding you need to improve your patients' chances for a healthier, cancer-free life.Explains how the latest developments in biologic therapy apply to leukemias and lymphomas.Provides exhaustive coverage of combined modality cancer treatment, helping you determine when and how to integrate modalities in patient treatment.Ensures that you are fully up to date thanks to easy, mobile access to quarterly updates. 606 $aLeukemia 606 $aLymphoma 606 $aNeoplasms by Histologic Type 606 $aNeoplasms 606 $aDisease 606 $aHematologic Diseases$2HILCC 606 $aMedicine$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 2$aLeukemia. 615 2$aLymphoma. 615 2$aNeoplasms by Histologic Type. 615 2$aNeoplasms. 615 2$aDisease. 615 7$aHematologic Diseases 615 7$aMedicine 615 7$aHealth & Biological Sciences 676 $a616.99/419 702 $aLawrence$b Theodore S. 702 $aLawrence$b Theodore S 702 $aRosenberg$b Steven A. 702 $aDeVita$b Vincent T.$cJr.,$f1935- 702 $aDeVita$b Vincent T 702 $aRosenberg$b Steven A 801 0$bPQKB 906 $aBOOK 912 $a9910967735203321 996 $aLymphomas and leukemias$94477975 997 $aUNINA